- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Lung Non-Small Cell Carcinoma in United Kingdom
Total 4550 results
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung CancerUnited States
-
Mayo ClinicRecruitingMetastatic Lung Non-Small Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Resectable Lung Non-Small Cell Carcinoma | Metastatic Malignant Solid Neoplasm | Metastatic Bladder Urothelial Carcinoma | Metastatic Colorectal Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Locally... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung Carcinoma | Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura | Advanced Esophageal Cancers | Primary Small Cell Lung Cancers | Pleural MesotheliomasUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | Mesothelin PositiveUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
National Cancer Institute (NCI)Active, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, Canada
-
University of Colorado, DenverRecruitingNon-Small Cell Lung Cancer | ALK Gene Mutation | EGFR Gene Mutation | BRAF V600E | Non-Small Cell Carcinoma of Lung, TNM Stage 4 | ROSE Cluster 1United States
-
University of UtahRecruitingNon Small Cell Lung CancerUnited States
-
AstraZenecaRecruitingCarcinoma | Non-Small-Cell LungChina, Israel, Spain, United States, Canada, Italy, Korea, Republic of, Belgium, Bulgaria, Vietnam, Japan, United Kingdom, Brazil, France, Philippines, Taiwan, Thailand, Germany, Poland, Austria, Greece, Turkey, Argentina, Hong Kong, Chile and more
-
Syndax PharmaceuticalsTerminatedNon Small Cell Lung CancerUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI)RecruitingNon Small Cell Lung Cancer | Non-small Cell Lung CancerUnited States, Canada
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Boehringer IngelheimCompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Stage III Non-small Cell Lung CancerUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Lymphoma | Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Neoplasm Metastasis | Hodgkin Disease | Pancreatic Adenocarcinoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Activating MutationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Spectrum Pharmaceuticals, IncActive, not recruitingEGFR Exon 20 Mutation | ERBB2 Gene Mutation | Recurrent Lung Non-Small Cell Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7United States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Heather WakeleeNovartis; Genentech, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC), Recurrent | Non-small Cell Lung Cancer (NSCLC), Stage IVUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Active, not recruitingRefractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8United States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedStage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterConquer Cancer FoundationActive, not recruitingNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalCompletedNon Small Cell Lung CancerUnited States
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationUnited States, Spain, Korea, Republic of, Taiwan, Italy, Australia, France
-
Verastem, Inc.AmgenRecruitingNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, United Kingdom, Netherlands, Belgium
-
Joseph J. Cullen, MD, FACSNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden...RecruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | NSCLC | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung CarcinomaUnited States
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States
-
University of Alabama at BirminghamNot yet recruiting
-
University of California, IrvineRecruitingNon Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingNon-small Cell Lung CancerUnited States
-
University of TennesseeCellSight Technologies, Inc.RecruitingNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalGenentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedNon-small Cell Lung CancerUnited States
-
University of Wisconsin, MadisonCompletedNon Small Cell Lung CancerUnited States
-
Massachusetts General HospitalCompleted
-
Massachusetts General HospitalAmerican Society of Clinical OncologyCompletedNon-small Cell Lung CancerUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminatedNon-small Cell Lung CancerUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminated
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Celgene CorporationCompletedNon-small Cell Lung CancerUnited States
-
Providence Health & ServicesNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationCompletedNon Small Cell Lung CancerUnited States
-
Milton S. Hershey Medical CenterTerminatedNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)TerminatedNon-small Cell Lung CancerUnited States
-
Heat BiologicsWithdrawnNon-small Cell Lung CancerUnited States
-
Sun Farm CorporationNational Center for Complementary and Integrative Health (NCCIH)UnknownNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaboratorsCompletedNon-small Cell Lung CancerUnited States
-
Power Life Sciences Inc.Not yet recruiting